000999 Stock Overview China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Add noteChina Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Competitors Price History & Performance
Summary of share price highs, lows and changes for China Resources Sanjiu Medical & Pharmaceutical Historical stock prices Current Share Price CN¥46.40 52 Week High CN¥52.55 52 Week Low CN¥36.24 Beta 0.40 1 Month Change 1.55% 3 Month Change 22.11% 1 Year Change 22.60% 3 Year Change 102.89% 5 Year Change 101.87% Change since IPO 126.00%
Recent News & Updates
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Proposes Profit Distribution Plan for the Third Quarter of 2024 Oct 29
Third quarter 2024 earnings released: EPS: CN¥0.45 (vs CN¥0.41 in 3Q 2023) Oct 26
Investor sentiment improves as stock rises 25% Sep 30
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. to Report Q3, 2024 Results on Oct 26, 2024 Sep 30
Investor sentiment deteriorates as stock falls 17% Sep 11
Second quarter 2024 earnings released: EPS: CN¥0.80 (vs CN¥0.57 in 2Q 2023) Aug 24 See more updates
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Proposes Profit Distribution Plan for the Third Quarter of 2024 Oct 29
Third quarter 2024 earnings released: EPS: CN¥0.45 (vs CN¥0.41 in 3Q 2023) Oct 26
Investor sentiment improves as stock rises 25% Sep 30
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. to Report Q3, 2024 Results on Oct 26, 2024 Sep 30
Investor sentiment deteriorates as stock falls 17% Sep 11
Second quarter 2024 earnings released: EPS: CN¥0.80 (vs CN¥0.57 in 2Q 2023) Aug 24
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. to Report First Half, 2024 Results on Aug 24, 2024 Jun 29
Dividend increased to CN¥1.50 Jun 08
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 14 June 2024 Jun 08
High number of new directors Apr 20 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., Annual General Meeting, Apr 19, 2024
Full year 2023 earnings released: EPS: CN¥2.90 (vs CN¥2.48 in FY 2022) Mar 23
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. to Report Fiscal Year 2023 Results on Mar 23, 2024 Dec 29
Third quarter 2023 earnings released: EPS: CN¥0.53 (vs CN¥0.53 in 3Q 2022) Nov 01
Second quarter 2023 earnings released: EPS: CN¥0.75 (vs CN¥0.60 in 2Q 2022) Aug 30
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Announces Implementation of Cash Dividend for 2022, Payable on 15 June 2023 Jun 09
Now 22% undervalued May 30
Full year 2022 earnings released: EPS: CN¥2.48 (vs CN¥2.09 in FY 2021) Mar 14
Now 20% undervalued Mar 14
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Provides Earnings Guidance for the Year Ended 31 December 2022 Jan 21
Investor sentiment improved over the past week Nov 18
High number of new directors Nov 16
Third quarter 2022 earnings released: EPS: CN¥0.53 (vs CN¥0.39 in 3Q 2021) Oct 30
Investor sentiment improved over the past week Oct 19
Second quarter 2022 earnings released: EPS: CN¥0.60 (vs CN¥0.73 in 2Q 2021) Aug 25
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2021, Payable on 12 August 2022 Aug 05
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021 Jun 26
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., Annual General Meeting, Jun 23, 2022 Jun 03 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) agreed to acquire 28% stake in KPC Pharmaceuticals, Inc. (SHSE:600422) from Holley Pharmaceutical Group Co., Ltd and Holley Group Company Limited for CNY 2.9 billion. May 10
First quarter 2022 earnings released: EPS: CN¥0.86 (vs CN¥0.66 in 1Q 2021) Apr 27
High number of new directors Apr 27
High number of new directors Apr 02
Investor sentiment improved over the past week Apr 01
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Proposes Cash Dividend as of 31 December 2021 Mar 29
Full year 2021 earnings: EPS in line with expectations, revenues disappoint Mar 13
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Announces Board Elections Mar 06
High number of new directors Jan 13
Investor sentiment improved over the past week Dec 25
Third quarter 2021 earnings released: EPS CN¥0.39 (vs CN¥0.51 in 3Q 2020) Oct 28
Investor sentiment improved over the past week Aug 30
Second quarter 2021 earnings released: EPS CN¥0.73 (vs CN¥0.54 in 2Q 2020) Aug 24
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Approves Final Cash Dividend for 2020 May 19
First quarter 2021 earnings released: EPS CN¥0.66 (vs CN¥0.54 in 1Q 2020) May 02 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Proposes Cash Dividend for the Year December 31, 2020
Full year 2020 earnings released: EPS CN¥1.63 (vs CN¥2.16 in FY 2019) Mar 19
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. to Report Fiscal Year 2020 Results on Mar 19, 2021 Feb 18
New 90-day low: CN¥24.96 Dec 24
Third quarter earnings released Oct 30
Third-quarter earnings released: Revenue misses expectations Oct 30
New 90-day low: CN¥26.02 Sep 24
New 90-day low - CN¥27.00 Sep 09
Earnings released Aug 26
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. to Report First Half, 2020 Results on Aug 26, 2020 Aug 07 Shareholder Returns 000999 CN Pharmaceuticals CN Market 7D 2.6% -1.9% -1.2% 1Y 22.6% -1.8% 11.8%
See full shareholder returns
Return vs Market: 000999 exceeded the CN Market which returned 11.8% over the past year.
Price Volatility Is 000999's price volatile compared to industry and market? 000999 volatility 000999 Average Weekly Movement 6.0% Pharmaceuticals Industry Average Movement 7.4% Market Average Movement 8.7% 10% most volatile stocks in CN Market 12.8% 10% least volatile stocks in CN Market 5.7%
Stable Share Price: 000999 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 000999's weekly volatility (6%) has been stable over the past year.
About the Company China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally. The company offers health consumer products (CHC), including cold, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products, such as anti-tumor, cardiovascular and cerebrovascular, digestive system, orthopedics, pediatrics, and other treatment areas; Chinese medicine injections; formula granules; and anti-infective drugs.
Show more China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Fundamentals Summary How do China Resources Sanjiu Medical & Pharmaceutical's earnings and revenue compare to its market cap? 000999 fundamental statistics Market cap CN¥59.59b Earnings (TTM ) CN¥3.41b Revenue (TTM ) CN¥25.87b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 000999 income statement (TTM ) Revenue CN¥25.87b Cost of Revenue CN¥12.10b Gross Profit CN¥13.78b Other Expenses CN¥10.36b Earnings CN¥3.41b
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 2.66 Gross Margin 53.24% Net Profit Margin 13.18% Debt/Equity Ratio 10.0%
How did 000999 perform over the long term?
See historical performance and comparison Dividends
4.3% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/22 15:32 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is covered by 42 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Changming He BOCI Research Ltd. Jessica Li BofA Global Research Shuchang Liu Changjiang Securities Co. LTD.
Show 39 more analysts